Organization
Erasmus MC - Kanker Instituut locatie Danïel den Hoed
4 abstracts
Abstract
Primary outcome analysis of the ORCHESTRA trial: A randomized phase III trial of additional tumor debulking to first-line palliative systemic therapy for patients with multiorgan metastatic colorectal cancer.Org: Radboud UMC, Erasmus Medical Center, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Amsterdam UMC location VUMC, Erasmus MC Cancer Institute,
Abstract
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, Influence, CTS-5)? A TEAM Pathology substudy.Org: The Ottawa Hospital Research Institute, McMaster University and Juravinski Cancer Centre, Ontario Institute for Cancer Research, Toronto, ON, Canada, Diagnostic Development, Toronto Allergy and Asthma Centre,
Abstract
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.Org: Cancer Research UK Scotland Centre, University of Edinburgh Cancer Research UK Centre, Unity Health Toronto, Biotheranostics, A Hologic Company, A Hologic Company,
Abstract
Analysis of significant weight gain in patients using alectinib for ALK-positive lung cancer.Org: Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Erasmus MC University Medical Center, Erasmus Medical Center, Erasmus MC Kankerinstituut, Department of Pulmonary Medicine,